282 related articles for article (PubMed ID: 11547365)
1. Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership.
Mesko JW; Brand RA; Iorio R; Gradisar I; Heekin R; Leighton R; Thornberry R
J Arthroplasty; 2001 Sep; 16(6):679-88. PubMed ID: 11547365
[TBL] [Abstract][Full Text] [Related]
2. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
3. Rationale for thromboprophylaxis in lower joint arthroplasty.
Colwell CW
Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
[TBL] [Abstract][Full Text] [Related]
4. Prolonged prophylaxis in orthopedic surgery: insights from the United States.
Anderson FA; White K;
Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():43-6. PubMed ID: 12232823
[TBL] [Abstract][Full Text] [Related]
5. DVT prophylaxis: better living through chemistry: affirms.
Pellegrini VD
Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
[TBL] [Abstract][Full Text] [Related]
6. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
8. The role of low molecular weight heparin in total knee arthroplasty.
Iobst CA; Friedman RJ
Am J Knee Surg; 1999; 12(1):55-60. PubMed ID: 10050695
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty.
Lachiewicz PF
Orthopedics; 2009 Dec; 32(12 Suppl):74-8. PubMed ID: 20201480
[TBL] [Abstract][Full Text] [Related]
10. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism prophylaxis after total hip or knee arthroplasty: a survey of Canadian orthopedic surgeons.
Gross M; Anderson DR; Nagpal S; O'Brien B
Can J Surg; 1999 Dec; 42(6):457-61. PubMed ID: 10593248
[TBL] [Abstract][Full Text] [Related]
12. Low-dose warfarin coupled with lower leg compression is effective prophylaxis against thromboembolic disease after hip arthroplasty.
Bern M; Deshmukh RV; Nelson R; Bierbaum B; Sevier N; Howie N; Losina E; Katz JN
J Arthroplasty; 2007 Aug; 22(5):644-50. PubMed ID: 17689770
[TBL] [Abstract][Full Text] [Related]
13. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.
Anderson FA; Hirsh J; White K; Fitzgerald RH;
Chest; 2003 Dec; 124(6 Suppl):349S-356S. PubMed ID: 14668417
[TBL] [Abstract][Full Text] [Related]
15. Multimodal venous thromboembolic disease prevention for patients undergoing primary or revision total joint arthroplasty: the role of aspirin.
Berend KR; Lombardi AV
Am J Orthop (Belle Mead NJ); 2006 Jan; 35(1):24-9. PubMed ID: 16475420
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of thromboprophylaxis in the management of total hip and knee arthroplasty.
Skinner HB; Schulz MM
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):20-30. PubMed ID: 12349892
[TBL] [Abstract][Full Text] [Related]
17. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of deep venous thrombosis prophylaxis in low-risk patients undergoing total knee arthroplasty.
Callaghan JJ; Warth LC; Hoballah JJ; Liu SS; Wells CW
J Arthroplasty; 2008 Sep; 23(6 Suppl 1):20-4. PubMed ID: 18722299
[TBL] [Abstract][Full Text] [Related]
19. Current recommendations for extended out-of-hospital thromboprophylaxis following total hip arthroplasty.
Krotenberg R
Am J Orthop (Belle Mead NJ); 2004 Apr; 33(4):180-4. PubMed ID: 15132325
[TBL] [Abstract][Full Text] [Related]
20. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations.
Miric A; Lombardi P; Sculco TP
Am J Orthop (Belle Mead NJ); 2000 Apr; 29(4):269-74. PubMed ID: 10784014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
